Carnitine deficiency in epileptic children treated with a diversity of anti-epileptic regimens

Sherine El Mously1, Hadeer Abdel Ghaffar1, Remon Magdy1

  • 1Faculty of Medicine, Fayoum University, Fayoum City, 63611 Egypt.

Insights

Carnitine deficiency is common in children with epilepsy. Using valproate with other antiepileptic drugs (AEDs) is the primary risk factor identified in this study.

Area of Science:

  • Pediatric Neurology
  • Clinical Chemistry

Background:

  • Carnitine deficiency is prevalent in epileptic patients.
  • Risk factors include polytherapy with antiepileptic drugs (AEDs), young age, and neurological impairments.

Purpose of the Study:

  • To investigate carnitine deficiency levels and associated risk factors in children with idiopathic epilepsy on various AEDs.

Main Methods:

  • Serum carnitine levels were measured using enzyme-linked immune sorbent assay (ELISA).
  • Fifty children with idiopathic epilepsy and 40 age-matched controls were included.

Main Results:

  • Epileptic children exhibited lower mean carnitine levels than controls (p=0.04).
  • Patients on valproate combined with other AEDs showed significantly lower carnitine levels (p=0.03).
  • Monotherapy also correlated with a high percentage of carnitine deficiency (p=0.04).

Conclusions:

  • Carnitine deficiency is a common issue in the studied pediatric epilepsy population.
  • Concurrent use of valproate and other AEDs is the most significant risk factor for carnitine deficiency in epileptic children.
Abstract

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.5K
Diversity of Archaea I01:30

Diversity of Archaea I

Archaea, a domain of single-celled microorganisms, are classified into five major phyla based on genetic and biochemical characteristics: Euryarchaeota, Crenarchaeota, Thaumarchaeota, Korarchaeota, and Nanoarchaeota. Among these, the phylum Euryarchaeota is notable for its remarkable diversity in morphology, metabolism, and ecological adaptations.Morphological and Metabolic DiversityMembers of Euryarchaeota exhibit a variety of cellular shapes, including rods and cocci. Their metabolic pathways...
627
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
184
Cell Diversity01:13

Cell Diversity

The concept of a cell started with microscopic observations of dead cork tissue by Robert Hooke in 1665. Hooke coined the term "cell" based on the resemblance of the small subdivisions in the cork to the rooms that monks inhabited, called cells. About ten years later, Antonie van Leeuwenhoek became the first person to observe the living and moving cells under a microscope. In the century that followed, the theory that cells represented the basic unit of life developed.
Multicellular...
5.1K
Diversity of Archaea II01:24

Diversity of Archaea II

Archaea, one of the three domains of life, exhibit remarkable diversity and adaptability, thriving in both extreme and moderate environments. Historically, most identified archaea have been classified into two major phyla: Euryarchaeota and Crenarchaeota. However, recent molecular studies have expanded this classification to include three additional phyla: Thaumarchaeota, Nanoarchaeota, and Korarchaeota, each exhibiting unique characteristics and ecological roles.Thaumarchaeota: Mesophiles...
521
Diversity of Protists I01:15

Diversity of Protists I

Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
1.2K